Literature DB >> 9712338

von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.

A Blann1, A Bignell, C McCollum.   

Abstract

Plasma viscosity and fibrinogen are risk factors for cardiovascular disease and on rheological grounds, it is widely believed that the latter is a major determinant of the former. However, other plasma constituents may also be important determinants of plasma viscosity. Our aim was to determine whether or not levels of von Willebrand factor contributed to plasma viscosity. We measured plasma viscosity, fibrinogen, von Willebrand factor, immunoglobulins G, A and M, total, HDL- and LDL-cholesterol, triglycerides and albumin in 95 patients with peripheral arterial disease and in 120 healthy controls. A stepwise multivariate analysis was performed to determine the major influences of plasma viscosity. We also measured fibrinogen, von Willebrand factor, immunoglobulins G, A and M, total, HDL- and LDL-cholesterol, triglycerides, albumin and viscosity in 32 smokers as they successfully progressed to being non-smokers. The level of von Willebrand factor was an independent influence on plasma viscosity in the controls (P < 0.05), patients (P < 0.01) and in the combined group (P < 0.001). von Willebrand factor, fibrinogen and plasma viscosity, but not the immunoglobulins, lipoproteins or albumin, fell (P < 0.05) in smokers as they became non-smokers. We find that von Willebrand factor contributes to plasma viscosity, hence a reduction in levels of von Willebrand factor should result in a reduction in viscosity. These data may have implications for the pathogenesis of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712338     DOI: 10.1016/s0021-9150(98)00090-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Association of hyperviscosity and subclinical atherosclerosis in obese schoolchildren.

Authors:  Weihua Zhu; Mengxia Li; Xianmei Huang; Henning Neubauer
Journal:  Eur J Pediatr       Date:  2005-07-12       Impact factor: 3.183

2.  The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration.

Authors:  Selmin Toplan; Nuran Dariyerli; Semra Ozdemir; Mehmet Can Akyolcu; Hüsrev Hatemi; Günnur Yigit
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

3.  Association of Blood Viscosity With Mortality Among Patients Hospitalized With COVID-19.

Authors:  Daein Choi; Ori Waksman; Aleesha Shaik; Phyu Mar; Qinzhong Chen; Daniel J Cho; HyoungSup Kim; Robin L Smith; Sascha N Goonewardena; Robert S Rosenson
Journal:  J Am Coll Cardiol       Date:  2022-07-26       Impact factor: 27.203

4.  Effects of particulate matter on the pulmonary and vascular system: time course in spontaneously hypertensive rats.

Authors:  Miriam E Gerlofs-Nijland; A John F Boere; Daan Lac Leseman; Jan Ama Dormans; Thomas Sandström; Raimo O Salonen; Leendert van Bree; Flemming R Cassee
Journal:  Part Fibre Toxicol       Date:  2005-03-24       Impact factor: 9.400

5.  Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect.

Authors:  Brian K Nordskog; Buddy G Brown; Kristin M Marano; Leanne R Campell; Bobbette A Jones; Michael F Borgerding
Journal:  Inhal Toxicol       Date:  2015-03-19       Impact factor: 2.724

6.  The Association between Whole Blood Viscosity and Coronary Collateral Circulation in Patients with Chronic Total Occlusion.

Authors:  Mehmet Serkan Cetin; Elif Hande Ozcan Cetin; Kevser Gülcihan Balcı; Selahattin Aydin; Emek Ediboglu; Muhammed Fatih Bayraktar; Mustafa Mücahit Balcı; Orhan Maden; Ahmet Temizhan; Sinan Aydogdu
Journal:  Korean Circ J       Date:  2016-11-01       Impact factor: 3.243

7.  A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers.

Authors:  Frank Lüdicke; John Magnette; Gizelle Baker; Rolf Weitkunat
Journal:  Biomarkers       Date:  2015       Impact factor: 2.658

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.